English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduNew research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are associated with improved long-term survival compared to wedge resection for patients with early-stage non-small cell lung cancer.
Tag: Lung Cancer
MD Anderson’s Lauren Averett Byers receives TAMEST O’Donnell Award for seminal contributions to lung cancer research
Lauren Averett Byers, M.D., professor of Thoracic/Head & Neck Medical Oncology at The University of Texas MD Anderson Cancer Center, has received the 2025 Edith and Peter O’Donnell Award in Medicine from the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST). The award recognizes her fundamental discoveries and contributions to identifying novel therapeutic strategies for small cell lung cancer (SCLC), which have paved the way for personalized treatments, even in the most highly recalcitrant cancers.
MSK Awards and Appointments November 2024
NEW YORK, December 4, 2024 – Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:
Diabetes Drug Appears to Fight Lung Cancer — But Only in Overweight or Obese Patients
A widely accessible drug commonly used to control blood glucose levels in diabetic patients has the potential to strengthen the effects of immunotherapy and improve recurrence-free survival in people with lung cancer who are overweight or obese, according to a recently published article in the Journal of the National Cancer Institute.
New research sheds light on a surprising connection between COVID-19 and cancer regression
New research sheds light on a surprising connection between COVID-19 and cancer regression
Detección de indicios de cáncer de pulmón en el aliento exhalado
En un estudio publicado en la revista ACS Sensors, investigadores informan del desarrollo de sensores ultrasensibles a nanoescala que, en pruebas a pequeña escala, distinguen un cambio clave en la química del aliento de personas con cáncer de pulmón.
Detecting evidence of lung cancer in exhaled breath
Exhaled breath contains chemical clues to what’s going on inside the body, including diseases like lung cancer. And devising ways to sense these compounds could help doctors provide early diagnoses — and improve patients’ prospects. In a study in ACS Sensors, researchers report developing ultrasensitive, nanoscale sensors that in small-scale tests distinguished a key change in the chemistry of the breath of people with lung cancer. November is Lung Cancer Awareness Month.
Researchers awarded $2.5 million grant to increase lung cancer screenings in underserved communities
The funding will support a new initiative aimed at reducing disparities in lung cancer screening across Los Angeles County.
What you need to know about lung cancer
UCLA Health experts Amy Cummings, MD, PhD, and Sha’Shonda Revels, MD, address frequently asked questions about the disease.
Moffitt Study Links Methylmalonic Acid to Weakening of Immune Cells in Lung Cancer
A new study has found a surprising link between high levels of methylmalonic acid and the weakening of CD8+ T cells, shedding light on potential pathways through which aging may promote lung cancer progression. Moffitt Cancer Center researchers have found new insights into how metabolic changes associated with aging can impact immune responses against tumors.
Study seeks rapid, paper-based test to detect cancer cells in cerebrospinal fluid
With time being of the essence for patients facing one of cancer’s most dire complications, UCLA researchers are working to create a new test to detect cancer’s spread to the central nervous system on the same day as the doctor’s visit.
Dual immunotherapy plus chemotherapy benefits specific subset of patients with lung cancer
Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor genes were more likely to benefit from adding the immunotherapy tremelimumab to a combination of durvalumab plus chemotherapy to overcome treatment resistance typically seen in this patient population.
Cedars-Sinai to Participate in Largest AAPI Cancer Initiative
Cedars-Sinai Cancer is advancing its commitment to diversity in research by participating in the largest-ever national study of cancer risk factors in Asian Americans. Investigators are hoping to learn why Asian Americans have disproportionately high rates of many types of cancer.
New addition to standard-of-care treatments for non-small-cell lung cancer patients has potential to increase progression-free survival
Houston Methodist researchers have developed an advanced mathematical model that predicts how novel treatment combinations could significantly extend progression-free survival for patients with non-small-cell lung cancer (NSCLC), the most common type of lung cancer.
Faster, more sensitive lung cancer detection from a blood draw
A new way of diagnosing lung cancer with a blood draw is 10 times faster and 14 times more sensitive than earlier methods, according to University of Michigan researchers.
MD Anderson Research Highlights for October 2, 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Timing matters when adding immunotherapy to chemoradiation for patients with limited-stage small cell lung cancer
People with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both treatments are given at the same time, new research finds.
MD Anderson Research Highlights for September 19, 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Mark Awad Named Chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center
Mark Awad, MD, PhD, has been appointed Chief of the Thoracic Oncology Service within the Solid Tumor Oncology Division, Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK).
MD Anderson Research Highlights Special Edition: 2024 World Conference on Lung Cancer
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. This special edition features compelling data on lung cancer advances presented by MD Anderson researchers at the 2024 World Conference on Lung Cancer.
Immunotherapy Before and After Lung Cancer Surgery Reduces Death Risk, Disease Recurrence
People with operable non-small cell lung cancers may fare better over the next few years by receiving immunotherapy treatments before and after surgery instead of only before surgery, according to a new analysis by Johns Hopkins Kimmel Cancer Center investigators.
TGF-Beta and RAS Signaling Are Both Required for Lung Cancer Metastasis, Study Finds
MSK researchers have identified two signaling pathways that work together to spur the spread of lung cancer. Taking away one of those signals could help slow or stop metastasis, findings in animal models suggest.
Radiation oncology research and clinical trial results to be featured at ASTRO’s Annual Meeting in Washington
The American Society for Radiation Oncology (ASTRO) announced today the seven studies to be highlighted in the 2024 ASTRO Annual Meeting press program. Researchers will discuss their findings in news briefings held September 30 and October 1 at the Walter E. Washington Convention Center in Washington, D.C. and via live webcast.
Cleveland Clinic expert: Study to develop a blood-based lung cancer detection test published in Cancer Discovery
Cleveland Clinic expert is available to discuss research published in Cancer Discovery. According to the American Cancer Society, lung cancer is the number-one cancer killer of both men and women in the United States, accounting for over 125,000 deaths per…
Study: Some Lung Cancer Disparities Lessen in South Florida
When it comes to cancer disparities, community may count. A new study in the Journal of the National Cancer Institute showed that although Hispanic non-small cell lung cancer patients tend to be diagnosed at later stages than White patients, that disadvantage disappears in South Florida.
International Lung Cancer Experts Seek Public Comments on Updated Molecular Testing Guideline to Improve Patient Selection and Targeted Therapies
The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) announced today the open comment period for the revised 2018 evidence-based guideline, “Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors.”
MD Anderson Research Highlights for August 21, 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Invenio Imaging Announces First Patients Enrolled in US Pivotal Study of AI-Based Image Analysis Module for Lung Cancer
Invenio Imaging, a leader in intraoperative fresh tissue imaging and artificial intelligence (AI), announced today the enrollment of the first patients in a US pivotal study of its AI-based image analysis module for lung cancer.
MD Anderson Research Highlights for July 11, 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Ochsner Medical Center – Baton Rouge performs robotic-assisted lung biopsy
Ochsner Medical Center – Baton Rouge now offers robotic-assisted bronchoscopy using the Ion robotic platform, a new, minimally invasive option for lung biopsy.
Study supports precision radiation therapy in lung cancer
Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative 3D-conformal radiotherapy (3D-CRT) for patients with unresectable, locally advanced non-small cell lung cancer (NSCLC).
DITCHING THE VAPE MAY BE BEST WAY TO BREATHE EASY this “Love Your Lungs” Week
As many as 70% of smokers looking to quit say they enlist the help of e-cigarettes or vaping devices to kick the habit – according to a recent study. Because the devices allow you to control the strength of nicotine,…
The Harvey L. Neiman Health Policy Institute Launches Cancer Equity Compass
The Harvey L. Neiman Health Policy Institute announces the public launch of a new online tool that reveals the overlap between cancer disparities and social determinants of health (SDOH) using advanced heat maps of U.S. counties. The Cancer Equity Compass can identify high-opportunity targets for policies and programs to achieve equitable health outcomes in underserved populations.
UC Davis total-body advanced PET scanner EXPLORER can visualize dual blood supply in lung cancer
New study shows UC Davis total-body advanced PET scanner EXPLORER can visualize dual blood supply in lungs and effectively evaluate lung cancer and track treatment progress.
New Study Finds Most Eligible U.S. Adults not Getting Screened for Lung Cancer
A new study led by American Cancer Society researchers shows less than one-in-five eligible individuals in the United States were up-to-date with recommended lung cancer screening. The screening uptake was much lower in persons without health insurance or usual source of care and in Southern states with the highest lung cancer burden.
Dr. Estelamari Rodriguez Honored as GRACE Patient Educator of the Year
In recognition of her work breaking down language barriers around the world by creating Spanish-language educational content about lung cancer for patients and caregivers, Sylvester Comprehensive Cancer Center’s Dr. Estelamari Rodriguez has been honored as GRACE Patient Educator of the Year.
New Pathways for Treating Never-Smoker Lung Cancer Revealed
Korean joint research team have elucidated the overexpression of estrogen signaling pathways in specific Korean never-smoking lung cancer cases using multi-omics analysis and proposed the anti-cancer drug saracatinib as a targeted therapeutic agent.
Stress from living in violent neighborhoods tied to aggressive lung cancer in Black men
Exposure to increased neighborhood violence has the power to change the glucocorticoid receptor (GR) for the stress hormone, cortisol, which may influence the aggressiveness of lung cancer, according to data presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Study: Access to Targeted Lung Cancer Drug Is Cost-Prohibitive Globally
A new study that examined the cost-effectiveness of durvalumab, a targeted immunotherapy for lung cancer, could help guide drug-pricing strategies to reduce financial burdens and increase the number of patients who benefit from treatment.
Phase 1/2 trial of the XPO1 inhibitor selinexor in combination with docetaxel in previously treated, advanced KRAS mutant non-small cell lung cancer (NSCLC)
Background: KRAS mutant NSCLC remains a therapeutic challenge. Although KRAS G12C inhibitors are now approved for cases harboring that specific mutation, their efficacy is modest and the G12C variant accounts for only 40% of KRAS mutations in NSCLC. To date,…
A meta-analysis of models for predicting the incidence of brain metastasis in patients with lung cancer
Background: Brain metastasis (BM) represents a significant clinical challenge in the management of lung cancer, impacting patient prognosis and treatment decisions. While various predictive models have been developed to assess the risk of BM development, their performance and applicability remain under…
Mount Sinai Experts to Present New Research on Long COVID, Lung Cancer, Asthma, Sleep Apnea, and More at ATS 2024 International Conference
Available for interview on breaking news, trending topics in respiratory medicine
EX-CIGARETTE SMOKERS WHO VAPE MAY BE AT HIGHER RISK FOR LUNG CANCER
Former cigarette smokers who use e-cigarettes or vaping devices may be at higher risk for lung cancer than those who don’t vape, according to research published at the ATS 2024 International Conference.
New imaging software improves lung diagnosis for 30% of patients who can’t tolerate contrast dye; has added diagnostic benefits for all patients
For up to 30% of patients who are allergic to medical contrast dye or have a dye restriction because of other health conditions, they might find that it takes longer to get a diagnosis when it comes to life-threatening lung issues such as pulmonary embolism.
Tip Sheet: Funding awarded to two ovarian cancer research projects, progress towards liquid biopsies for lung cancer — and cannabis and alcohol use in patients
Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news.
Study: Hillocks challenge our understanding of lung biology
A research team from Tufts University School of Medicine and Massachusetts General Hospital is now reporting evidence that hillocks and their stem cells are physiologically distinct from other cells within the lung and consist of a stratified outer layer of scale-like squamous cells that protect an underlying layer of rapidly expanding basal stem cells that are capable of restoring airway tissue after injury.
Living with Stage 3 lung cancer in your 80s and 90s
Mickey Allen was 89 years old when she was diagnosed with Stage 3B lung cancer. How did her age impact her treatment options? University of Chicago Medicine oncologists explain what factors they consider when creating treatment plans for patients in their 80s and 90s.
New study confirms community pharmacies can help people quit smoking
New study by UC Davis researchers shows how pharmacies may provide crucial access to tobacco cessation tools that help people successfully quit smoking.
Moffitt Researchers Discover New Therapeutic Target for Non-Small Cell Lung Cancer
A new Moffitt Cancer Center study published in the journal Immunity offers insight into how lung cancer cells evade the protective immune system, potentially opening a door for novel antibody-based immunotherapies. Their study centers on a molecule called Jagged2, which plays a primary role in fueling the aggressiveness and immune evasion capacity of lung cancer.
University of Maryland Greenebaum Comprehensive Cancer Center and AstraZeneca Partner to Enhance Community-Based Lung Cancer Screening and Detection for Marylanders at High Risk
With only a small percentage of Marylanders at high risk for lung cancer getting the recommended annual screening, the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) today launched a new statewide effort to increase annual screenings.